limit evalu therapi inflammatori bowel diseas suggest futur research current treatment inflammatori bowel diseas ibd therapi variabl consist support similar manag ulcer coliti UC crohn diseas CD relat disord therapi nonspecif variat therapeut practic result fact etiolog diseas obscur limit knowledg biolog pharmacolog action drug sulfasalazin compound steroid azathioprin inadequ understand genet differ drug metabol insuffici awar factor drug effici concurr use antimotil drug cigarett smoke food combin variabl patient group extent sever diseas incomplet document clinic statu patient time therapeut trial futur advanc treatment new inform natur ibd drug pharmacolog bioavail collabor studi clinician clinic investig basic scientist import area ibd research biolog intestin epithelium natur ibd inflammatori reaction gut mucos immun regul applic new biotechnolog repres experiment anim model decis multicent therapeut studi agreement definit ulcer coliti crohn diseas accur character patient group accept object criteria ibd sever activ reliabl indic therapeut respons 